Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioClinica
BioClinica
Activities:
Regulatory
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
Bioclinica acquires Clinverse
Expanding into financial management solutions for clinical trials
Regulatory
BioClinica acquires Synowledge
Adds capabilities in pharmacovigilance and regulatory technology, data analysis and business process management
Regulatory
BioClinica expands eClinical leadership team
Andrew Masters and Angelo Stortini take key roles in the eClinical solutions team
Regulatory
BioClinica software offers better sponsor control over trial timelines
Programme has potential to change the way sponsors and CROs use technology to run clinical trials
Regulatory
GSK to use BioClinica Interactive Web Response solution
The pharma giant has signed a multi-year agreement for global trial management technology
Subscribe now